SCHEMBL8040593

SCHEMBL8040593

CCOC(=O)c1c(CC)nc(-c2ccc(Cl)cc2)nc1NC(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.47
ALDH1A1 P00352 5/20 0.44
NPSR1 Q6W5P4 3/20 0.44
KDM4E B2RXH2 3/20 0.44
LMNA P02545 2/20 0.44
HPGD P15428 1/20 0.44
MAPT P10636 3/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPC1 O15118 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GABRA2 P47869 2/20 0.43
GABRB2 P47870 2/20 0.43
FOS P01100 1/20 0.43
JUN P05412 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
TARBP2 Q15633 1/20 0.42
RXRA P19793 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8042776 0.91 TSHR (0.48) TSHRALDH1A1NPSR1KDM4ELMNA
SCHEMBL8041719 0.89 TSHR (0.59) TSHRALDH1A1NPSR1KDM4ELMNA
SCHEMBL8030010 0.86 RXRA (0.47) TSHRALDH1A1NPSR1KDM4EHPGD
SCHEMBL8038586 0.83 ALDH1A1 (0.45) TSHRALDH1A1NPSR1KDM4ELMNA
SCHEMBL8040307 0.82 GABRA2 (0.49) ALDH1A1KDM4ELMNAHPGDMAPT
SCHEMBL8034844 0.82 CASP3 (0.46) TSHRALDH1A1NPSR1KDM4ELMNA
SCHEMBL8040669 0.81 NPSR1 (0.42) TSHRALDH1A1NPSR1KDM4ELMNA
SCHEMBL4009023 0.78 DPP4 (0.42) TSHRALDH1A1NPSR1LMNAMAPT
SCHEMBL8037266 0.77 GABRA2 (0.45) ALDH1A1KDM4ELMNAMAPTMEN1
SCHEMBL8035080 0.76 TSHR (0.47) TSHRALDH1A1NPSR1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080242-A1 SUBSTITUTED 4-AMINOPYRIMIDINE-5-CARBOXYLIC ACID AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed